Finland's CurifyLabs has raised a $14m Series A to expand in the US, where pharmacies in 21 states use its 3D printers to make custom medicine doses.

CurifyLabs, a health technology company transforming how personalized medicines are made, today announced the closing of a $14 million Series A funding round. The round was co-led by Sandwater and ...

CurifyLabs has secured Series A funding to expand its operations in the US, strengthen its supply chain and accelerate ...

SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- CurifyLabs today announced the rollout of its latest innovation in compounding pharmacy technology, the CurifyLabs PharmaPrinter Aurum. The newest ...

APL, one of Sweden’s largest manufacturers of extemporaneous medicines and a leading contract development and manufacturing organization (CDMO), has announced a partnership with CurifyLabs, a Finnish ...

Apotek Produktion & Laboratorier (APL), one of the largest manufacturers of extemporaneous medicines and a leading CDMO in Sweden, has joined forces with CurifyLabs, a Finnish health tech company ...

HELSINKI and ATLANTA, Oct. 14, 2025 /PRNewswire/ -- CurifyLabs, a global innovator in 3D printing for compounded medications, today announced the release of its next-generation software platform. The ...

Pharmaceutical manufacturing is closely linked to mass production. In order for medicines to be sold cheaply, they often have to be made in huge amounts. But what happens if you need a drug in a ...

PharmaPrinter Aurum streamlines pharmacy workflows with enhanced speed, simplified cleaning, and a modern, compact design Founded in 2021, CurifyLabs is transforming how personalized medicines are ...